NATCAPSUQBSENatural Capsules LtdMediumNeutral
Announced Wed, 27 May · 21:11 IST

Please find attached the Intimation of Allotment of 25,000 Equity Shares under ESOP.

Pat Growth 25pctResults View source PDF

NATCAPSUQ · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-7.1%1-day move
₹169.99
prior close
₹160.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+3.7+2.5+2.5+1.5-7.1-7.8-7.1-8.6-7.3-8.2-5.3-10.4
Up moveDown movePending
AI summary

Natural Capsules Limited allotted 25,000 equity shares of Rs 10 each fully paid up against exercise of vested options under Employee Stock Option Plan 2025. The paid-up capital increased from Rs 10,38,61,540 to Rs 10,41,11,540. The exercise price was Rs 10 per option, raising Rs 2.5 Lakhs. Shares rank pari-passu with existing equity. Diluted EPS stands at Rs 10.72. Additionally, the Board approved FY2026 audited standalone results showing revenue of Rs 17,377.09 Lakhs (up 3.5% YoY) and net profit of Rs 1,121.39 Lakhs (up 67% YoY), with consolidated net profit at Rs 1,707.36 Lakhs. Unmodified auditor opinion confirmed. Key appointments made include Mr. Laxminarayan Moondra as Whole-Time Director and Mr. Akshay Dutta as Company Secretary.

Likely market impact

The ESOP allotment is dilutive but marginal. Strong PAT growth of 67% YoY on standalone basis is positive for shareholders. Unmodified auditor opinion indicates no going concern issues.